Metraipolis › archive › dc_b5ceaf06b1ea

Empirical Meropenem Versus Piperacillin/Tazobactam for Critically Ill Adults With Sepsis: Feasibility of a Randomised Trial — Europe PMC PMID:42674465

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42674465
DOI
10.1111/aas.70324
License (as archived)
solo-consultazione
Archived
2026-10-07T17:03:50.652Z
SHA-256 of the archived text
18b912afdf76c7bb1f1e168abb78f0358770387d6681dfb5fbd319c39d6fbbc5
Stable URL of this page
https://metraipolis.com/documento/dc_b5ceaf06b1ea

How to cite

Empirical Meropenem Versus Piperacillin/Tazobactam for Critically Ill Adults With Sepsis: Feasibility of a Randomised Trial — Europe PMC PMID:42674465 — Europe PMC (en), https://europepmc.org/article/MED/42674465 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b5ceaf06b1ea (Metraipolis archive dc_b5ceaf06b1ea, sha256 18b912afdf76c7bb1f1e168abb78f0358770387d6681dfb5fbd319c39d6fbbc5)
BibTeX
@misc{dcb5ceaf06b1ea,
  title = {Empirical Meropenem Versus Piperacillin/Tazobactam for Critically Ill Adults With Sepsis: Feasibility of a Randomised Trial — Europe PMC PMID:42674465},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42674465},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b5ceaf06b1ea; sha256 18b912afdf76c7bb1f1e168abb78f0358770387d6681dfb5fbd319c39d6fbbc5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42674465. Agents can read the archived copy with the MCP tool read_document.